Pf-07921585

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

PF-07921585 is an experimental medicine being studied by Pfizer. It is not yet approved for treating colorectal cancer or any other condition. Early clinical trials (Phase 1) have explored PF-07921585 alone and in combination with other drugs, including an immunotherapy called sasanlimab. These trials aimed to find a safe dose and see if the drug has any activity against cancer. One part of the trial specifically looked at PF-07921585 in combination with sasanlimab for people with microsatellite stable (MSS) metastatic colorectal cancer. The trials have been terminated. The drug is designed to target specific proteins involved in cancer cell growth and survival. More research is needed to determine if it is effective and safe for colorectal cancer patients.

Mechanism of Action

PF-07921585 is being investigated as a potential cancer treatment. It targets specific proteins within cancer cells that are important for their growth and survival. The specific proteins targeted by PF-07921585 are being characterized in clinical trials. It has been studied both alone and in combination with other therapies, like immunotherapy (sasanlimab), to see if these combinations are effective.

Side Effects

Because PF-07921585 is still in early-stage clinical trials The full range of potential side effects is not yet known. Side effects observed in the Phase 1 trials are still being evaluated. As with any experimental drug Participants in the trials experienced side effects Which are being carefully monitored by the researchers to assess the drug's safety.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT06580938 Phase 1
Terminated
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
United States

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
787 trials
Leucovorin
Other Medications
648 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.